{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Liver+Steatoses&page=2",
    "query": {
      "condition": "Liver Steatoses",
      "page": 2
    },
    "page_size": 10
  },
  "pagination": {
    "page": 2,
    "page_size": 10,
    "total_count": 10,
    "total_pages": 1,
    "next_page_url": null,
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Liver+Steatoses&page=1&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-06-26T14:13:57.587Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT05320146",
      "title": "A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Nonalcoholic Steatohepatitis (NASH)"
      ],
      "interventions": [
        {
          "name": "MRI-PDFF",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "Corcept Therapeutics",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": null,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "75 Years",
        "sex": "ALL",
        "summary": "18 Years to 75 Years"
      },
      "enrollment_count": 22,
      "start_date": "2022-03-04",
      "completion_date": "2023-07-18",
      "has_results": false,
      "last_update_posted_date": "2024-08-19",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 9,
      "location_summary": "Chandler, Arizona • Tucson, Arizona • Panorama City, California + 6 more",
      "locations": [
        {
          "city": "Chandler",
          "state": "Arizona"
        },
        {
          "city": "Tucson",
          "state": "Arizona"
        },
        {
          "city": "Panorama City",
          "state": "California"
        },
        {
          "city": "Santa Ana",
          "state": "California"
        },
        {
          "city": "Austin",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05320146"
    },
    {
      "nct_id": "NCT03744182",
      "title": "A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "NAFLD"
      ],
      "interventions": [
        {
          "name": "HM15211",
          "type": "DRUG"
        },
        {
          "name": "Placebo of HM15211",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Hanmi Pharmaceutical Company Limited",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "65 Years",
        "sex": "ALL",
        "summary": "18 Years to 65 Years"
      },
      "enrollment_count": 66,
      "start_date": "2018-11-01",
      "completion_date": "2020-03-18",
      "has_results": true,
      "last_update_posted_date": "2025-01-27",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 1,
      "location_summary": "Chula Vista, California",
      "locations": [
        {
          "city": "Chula Vista",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03744182"
    },
    {
      "nct_id": "NCT03205345",
      "title": "Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis",
      "overall_status": "UNKNOWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Decompensated Cirrhosis"
      ],
      "interventions": [
        {
          "name": "Emricasan (25 mg)",
          "type": "DRUG"
        },
        {
          "name": "Emricasan (5 mg)",
          "type": "DRUG"
        },
        {
          "name": "Placebo",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Conatus Pharmaceuticals Inc.",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 210,
      "start_date": "2017-06-28",
      "completion_date": "2019-08",
      "has_results": false,
      "last_update_posted_date": "2019-03-19",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 76,
      "location_summary": "Chandler, Arizona • Phoenix, Arizona • Tucson, Arizona + 59 more",
      "locations": [
        {
          "city": "Chandler",
          "state": "Arizona"
        },
        {
          "city": "Phoenix",
          "state": "Arizona"
        },
        {
          "city": "Phoenix",
          "state": "Arizona"
        },
        {
          "city": "Tucson",
          "state": "Arizona"
        },
        {
          "city": "Fresno",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03205345"
    },
    {
      "nct_id": "NCT01511523",
      "title": "Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)",
      "overall_status": "UNKNOWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Non Alcoholic Fatty Liver Disease"
      ],
      "interventions": [
        {
          "name": "RGMA001",
          "type": "DIETARY_SUPPLEMENT"
        },
        {
          "name": "Sugar Pill",
          "type": "DIETARY_SUPPLEMENT"
        }
      ],
      "intervention_types": [
        "DIETARY_SUPPLEMENT"
      ],
      "sponsor": "Biovil Research Group, LLC",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 40,
      "start_date": "2012-01",
      "completion_date": "2012-10",
      "has_results": false,
      "last_update_posted_date": "2012-03-16",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 1,
      "location_summary": "Fayetteville, North Carolina",
      "locations": [
        {
          "city": "Fayetteville",
          "state": "North Carolina"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01511523"
    },
    {
      "nct_id": "NCT01403402",
      "title": "Congenital Muscle Disease Study of Patient and Family Reported Medical Information",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations)",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan)",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy)",
        "Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))",
        "Alpha-Dystroglycanopathy (Fukuyama CMD)",
        "Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I))",
        "Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K))",
        "Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M))",
        "Alpha-Dystroglycanopathy (LGMDR14 POMT2 Related (Formerly LGMD2N))",
        "Alpha-Dystroglycanopathy (LGMDR15 POMGnT1 Related (Formerly LGMD2O))",
        "Alpha-Dystroglycanopathy (LGMDR19 GMPPB Related (Formerly LGMD2T))",
        "Alpha-Dystroglycanopathy (LGMDR20 ISPD Related (Formerly LGMD2U))",
        "Alpha-Dystroglycanopathy (LGMDR24 POMGnT2 Related)",
        "Alpha-Dystroglycanopathy (Muscle Eye Brain Disease (MEB))",
        "Alpha-Dystroglycanopathy (Walker Warburg Syndrome (WWS))",
        "Choline Kinase B Receptor - CHKB",
        "Collagen VI Related Disorders",
        "Collagen XII Related Disorders",
        "Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive)",
        "Congenital Muscular Dystrophy With Cataracts and Intellectual Disability (MDCCAID)",
        "Congenital Muscular Dystrophy With Joint Hyperlaxity",
        "Congenital Muscular Dystrophy With Rigid Spine Related to ACTA1",
        "Emery-Dreifuss Muscular Dystrophy",
        "GOLGA2-related Congenital Muscle Dystrophy With Brain Involvement",
        "LMNA Related Disorders",
        "Merosin Deficient CMD (Full or Partial)",
        "Nesprin Related MD (SYNE1)",
        "SELENON Related Disorders (Previously Known as SEPN1)",
        "SELENON Related Myopathy (Aka SEPN1)",
        "Telethonin CMD",
        "Congenital Myasthenic Syndrome",
        "Limb-Girdle Muscular Dystrophy",
        "LGMDD01 - DNAJB6 (Formerly LGMD1D)",
        "LGMDD05 - Collagen VI Related Bethlem Myopathy (Dominant)",
        "LGMDR07 - Telethonin (TCAP) Related (Formerly LGMD2G)",
        "LGMDR08 - TRIM Related (Formerly LGMD2H)",
        "LGMDR09 - FKRP Related (Formerly LGMD2I)",
        "LGMDR10 - Titin (TTN) Related (Formerly LGMD2J)",
        "LGMDR11 - POMT1 Related (Formerly LGMD2K)",
        "LGMDR13 - Fukutin (FKTN) Related (Formerly LGMD2M)",
        "LGMDR14 - POMT2 Related (Formerly LGMD2N)",
        "LGMDR15 - POMGnT1 Related (Formerly LGMD2O)",
        "LGMDR16 - DAG1 Related Dystroglycanopathy (Formerly LGMD2P)",
        "LGMDR17 - Plectin (PLEC) Related (Formerly LGMD2Q)",
        "LGMDR18 - TRAPPC11 Related (Formerly LGMD2S)",
        "LGMDR19 - GMPPB Related (Formerly LGMD2T)",
        "LGMDR20 - ISPD Related (Formerly LGMD2U)",
        "LGMDR22 - Collagen VI Related Bethlem Myopathy (Recessive)",
        "LGMDR23 - LAMA2 Related",
        "LGMDR24 - POMGnT2 Related"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Cure CMD",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "ALL",
        "summary": "Not listed"
      },
      "enrollment_count": 4000,
      "start_date": "2009-09",
      "completion_date": "2029-09",
      "has_results": false,
      "last_update_posted_date": "2021-08-09",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 1,
      "location_summary": "Lakewood, California",
      "locations": [
        {
          "city": "Lakewood",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01403402"
    },
    {
      "nct_id": "NCT02506946",
      "title": "NAFLD in Adolescents and Young Adults With PCOS",
      "overall_status": "SUSPENDED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Polycystic Ovary Syndrome",
        "Non-Alcoholic Fatty Liver Disease",
        "Metabolic Syndrome"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Columbia University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "14 Years",
        "maximum_age": "25 Years",
        "sex": "FEMALE",
        "summary": "14 Years to 25 Years · Female only"
      },
      "enrollment_count": 80,
      "start_date": "2013-07",
      "completion_date": "2026-06",
      "has_results": false,
      "last_update_posted_date": "2025-10-14",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 1,
      "location_summary": "New York, New York",
      "locations": [
        {
          "city": "New York",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02506946"
    },
    {
      "nct_id": "NCT04997486",
      "title": "The Effect of Time-restricted Eating on Liver Metabolism",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "NAFLD",
        "Obesity",
        "Nutritional and Metabolic Diseases"
      ],
      "interventions": [
        {
          "name": "Time restricted eating",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "University of California, Davis",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "25 Years",
        "maximum_age": "75 Years",
        "sex": "ALL",
        "summary": "25 Years to 75 Years"
      },
      "enrollment_count": 5,
      "start_date": "2021-07-20",
      "completion_date": "2024-03-07",
      "has_results": false,
      "last_update_posted_date": "2024-11-25",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 1,
      "location_summary": "Davis, California",
      "locations": [
        {
          "city": "Davis",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04997486"
    },
    {
      "nct_id": "NCT03758742",
      "title": "Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Diabetes Mellitus, Type 2"
      ],
      "interventions": [
        {
          "name": "High-Fruit Diet",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "University of Alabama at Birmingham",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "20 Years",
        "maximum_age": "70 Years",
        "sex": "ALL",
        "summary": "20 Years to 70 Years"
      },
      "enrollment_count": 34,
      "start_date": "2019-09-10",
      "completion_date": "2023-09-05",
      "has_results": true,
      "last_update_posted_date": "2025-06-10",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 1,
      "location_summary": "Birmingham, Alabama",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03758742"
    },
    {
      "nct_id": "NCT04897594",
      "title": "AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "NASH - Nonalcoholic Steatohepatitis"
      ],
      "interventions": [
        {
          "name": "TERN-201",
          "type": "DRUG"
        },
        {
          "name": "Placebo",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "Terns, Inc.",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "75 Years",
        "sex": "ALL",
        "summary": "18 Years to 75 Years"
      },
      "enrollment_count": 52,
      "start_date": "2021-05-20",
      "completion_date": "2022-09-02",
      "has_results": true,
      "last_update_posted_date": "2024-06-07",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 11,
      "location_summary": "Tucson, Arizona • Coronado, California • Los Angeles, California + 5 more",
      "locations": [
        {
          "city": "Tucson",
          "state": "Arizona"
        },
        {
          "city": "Tucson",
          "state": "Arizona"
        },
        {
          "city": "Coronado",
          "state": "California"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Panorama City",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04897594"
    },
    {
      "nct_id": "NCT01371396",
      "title": "Effect of Dietary Macronutrient Composition",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Metabolic Syndrome",
        "Non-alcoholic Fatty Liver Disease",
        "Obesity"
      ],
      "interventions": [
        {
          "name": "Low-fat diet",
          "type": "OTHER"
        },
        {
          "name": "Low-carbohydrate diet",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "University of Texas Southwestern Medical Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "20 Years",
        "maximum_age": "65 Years",
        "sex": "ALL",
        "summary": "20 Years to 65 Years"
      },
      "enrollment_count": 24,
      "start_date": "2007-09-01",
      "completion_date": "2013-12-31",
      "has_results": false,
      "last_update_posted_date": "2019-02-06",
      "last_synced_at": "2026-06-26T14:13:57.587Z",
      "location_count": 1,
      "location_summary": "Dallas, Texas",
      "locations": [
        {
          "city": "Dallas",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01371396"
    }
  ]
}